Romain Diamand, Karsten Guenzel, Georges Mjaess, Yolène Lefebvre, Mariaconsiglia Ferriero, Giuseppe Simone, Alexandre Fourcade, Georges Fournier, Alexandre-Patrick Bui, Fayek Taha, Marco Oderda, Paolo Gontero, Katerina Rysankova, Adrian Bernal-Gomez, Alessandro Mastrorosa, Jean-Baptiste Roche, Gaelle Fiard, Rawad Abou Zahr, Guillaume Ploussard, Olivier Windisch, Quentin Novello, Daniel Benamran, Gina Delavar, Julien Anract, Nicolas Barry Delongchamps, Adam Halinski, Charles Dariane, Jan Benijts, Gregoire Assenmacher, Thierry Roumeguère, Alexandre Peltier
BACKGROUND AND OBJECTIVE: A notable paradigm shift has emerged in the choice of prostate biopsy approach, with a transition from transrectal biopsy (TRBx) to transperineal biopsy (TPBx) driven by the lower risk of severe urinary tract infections. The impact of this change on detection of clinically significant prostate cancer (csPCa) remains a subject of debate. Our aim was to compare the csPCa detection rate of TRBx and TPBx. METHODS: Patients who underwent magnetic resonance imaging (MRI)-targeted and systematic biopsies for clinically localized PCa at 15 European referral centers from 2016 to 2023 were included...
March 19, 2024: European Urology Focus